Quadrivalent HPV vaccination and the risk of adverse pregnancy outcomes

New England Journal of Medicine

Volumn 376, Issue 13, 2017, Pages 1223-1233

  Scheller, Nikolai M ^a   Pasternak, Björn ^a,b   Mølgaard Nielsen, Ditte ^a   Svanström, Henrik ^a   Hviid, Anders ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; COHORT ANALYSIS; CONGENITAL MALFORMATION; CONTROLLED STUDY; DENMARK; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG SAFETY; FEMALE; HUMAN; LOW BIRTH WEIGHT; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; RISK ASSESSMENT; SMALL FOR DATE INFANT; SPONTANEOUS ABORTION; STILLBIRTH; VACCINATION; ABORTION, SPONTANEOUS; CONGENITAL ABNORMALITIES; PREGNANCY; PREMATURE BIRTH; YOUNG ADULT;

ABORTION, SPONTANEOUS; ADULT; COHORT STUDIES; CONGENITAL ABNORMALITIES; DENMARK; FEMALE; HUMAN PAPILLOMAVIRUS RECOMBINANT VACCINE QUADRIVALENT, TYPES 6, 11, 16, 18; HUMANS; INFANT, LOW BIRTH WEIGHT; PREGNANCY; PREGNANCY OUTCOME; PREMATURE BIRTH; STILLBIRTH; VACCINATION; YOUNG ADULT;

EID: 85017006893     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1612296     Document Type: Article

References (25)

1. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010; 59: 626-9.
2. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56(RR-2): 1-24.
3. EMA to further clarify safety profile of human papillomavirus (HPV) vaccines. London: European Medicines Agency, 2015 (http://www.ema.europa.eu/docs/en-GB/document-library/Referrals-document/HPV-vaccines-20/Procedure-started/WC500189476.pdf).
4. Finer LB, Zolna MR. Unintended pregnancy in the United States: incidence and disparities, 2006. Contraception 2011; 84: 478-85.
5. Finer LB, Zolna MR. Declines in unintended pregnancy in the United States, 2008-2011. N Engl J Med 2016; 374: 843-52.
6. Markowitz LE, Dunne EF, Saraiya M, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2014; 63(RR-05): 1-30.
7. Wacholder S, Chen BE, Wilcox A, et al. Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials. BMJ 2010; 340: c712.
8. Garland SM, Ault KA, Gall SA, et al. Pregnancy and infant outcomes in the clinical trials of a human papillomavirus type 6/11/16/18 vaccine: a combined analysis of five randomized controlled trials. Obstet Gynecol 2009; 114: 1179-88.
9. Panagiotou OA, Befano BL, Gonzalez P, et al. Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial. BMJ 2015; 351: h4358.
10. Baril L, Rosillon D, Willame C, et al. Risk of spontaneous abortion and other pregnancy outcomes in 15-25 year old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom. Vaccine 2015; 33: 6884-91.
11. Dana A, Buchanan KM, Goss MA, et al. Pregnancy outcomes from the pregnancy registry of a human papillomavirus type 6/11/16/18 vaccine. Obstet Gynecol 2009; 114: 1170-8.
12. Goss MA, Lievano F, Buchanan KM, Seminack MM, Cunningham ML, Dana A. Final report on exposure during pregnancy from a pregnancy registry for quadrivalent human papillomavirus vaccine. Vaccine 2015; 33: 3422-8.
13. Knudsen LB, Olsen J. The Danish Medical Birth Registry. Dan Med Bull 1998; 45: 320-3.
14. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health 2011; 39: Suppl 7: 30-3.
15. Jørgensen FS. Ultrasonography of pregnant women in Denmark 1999-2000: description of the development since 1980-1990. Ugeskr Laeger 2003; 165: 4409-15. (In Danish.)
16. Kristensen J, Langhoff-Roos J, Skovgaard LT, Kristensen FB. Validation of the Danish Birth Registration. J Clin Epidemiol 1996; 49: 893-7.
17. Pedersen CB, Gøtzsche H, Møller JO, Mortensen PB. The Danish Civil Registration System: a cohort of eight million persons. Dan Med Bull 2006; 53: 441-9.
18. Hviid A. Postlicensure epidemiology of childhood vaccination: the Danish experience. Expert Rev Vaccines 2006; 5: 641-9.
19. Kildemoes HW, Sørensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health 2011; 39: Suppl 7: 38-41.
20. Larsen H, Nielsen GL, Bendsen J, Flint C, Olsen J, Sørensen HT. Predictive value and completeness of the registration of congenital abnormalities in three Danish population-based registries. Scand J Public Health 2003; 31: 12-6.
21. Lohse SR, Farkas DK, Lohse N, et al. Validation of spontaneous abortion diagnoses in the Danish National Registry of Patients. Clin Epidemiol 2010; 2: 247-50.
22. Buhimschi CS, Weiner CP. Medications in pregnancy and lactation: part 1. Teratology. Obstet Gynecol 2009; 113: 166-88.
23. Austin PC. Statistical criteria for selecting the optimal number of untreated subjects matched to each treated subject when using many-to-one matching on the propensity score. Am J Epidemiol 2010; 172: 1092-7.
24. National Center for Immunization and Respiratory Diseases. General recommendations on immunization - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011; 60(2): 1-64.
25. Validering af Landspatientregistret (LPR) med henblik på obstetrisk forskning og kvalitetssikring - et kvalitetsudviklingsprojekt. Sundhedsstyrelsen, Denmark: Center for Evaluering og Medicinsk Teknologivurdering, November 2003 (http://www.statensnet.dk/pligtarkiv/fremvis.pl?vaerkid=23080&reprid=0&iarkiv=1Accessed16).